Eli Lilly is expected to have its new obesity asset on the market with the triple-agonist retatrutide, reinforcing the shift towards portfolio led strategies that address different stages of treatment and patient needs rather than relying on a single flagship product
EVALUATION OF ORAL GLP-1 RECEPTOR AGONISTS: SAFETY & EFFICACY CONSIDERATIONS Although oral GLP-1 medications offer a more convenient alternative to injections, their safety is still under investigation
Semaglutide is an FDA-approved medication belonging to a class of drugs called GLP-1 receptor agonists
How long will results last
Carroll RC, Beattie EC, von Zastrow M, Malenka RC (2001)
By ensuring you have enough of the building blocks for both, you are providing your body with a dual-layered approach to wellness: building strong structures and defending them against the environment